Literature DB >> 14609100

Lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease.

R Sandikci1, S Türkmen, G Güvenen, H Ayabakan, P Gülcan, M Koldas, Z Ozbek Kir, N Yenice.   

Abstract

To evaluate plasma lipid peroxidation and enzymatic and non-enzymatic antioxidant systems in patients with Behçet's disease, plasma malondialdehyde levels and total antioxidant status, erythrocyte superoxide dismutase and whole blood glutathione peroxidase activities were studied in 15 patients with active disease and in 30 with inactive disease, and compared with 20 age-matched healthy control subjects. Plasma malondialdehyde levels were significantly higher in patients with active Behçet's disease than in patients with inactive disease, who had significantly higher levels than control subjects. The plasma total antioxidant status of both groups of patients was significantly lower than that of controls. Furthermore, whole blood glutathione peroxidase activity was significantly lower in patients with active versus inactive Behçet's disease. There were no significant differences in erythrocyte superoxide dismutase levels between the groups. In conclusion, there is an increase in oxidative stress in Behçet's disease. Despite this stress, the antioxidant system is deficient and inadequate, especially in patients who are in an active phase of the disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14609100     DOI: 10.1080/00015550310003782

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  11 in total

1.  Hypericum perforatum modulates apoptosis and calcium mobilization through voltage-gated and TRPM2 calcium channels in neutrophil of patients with Behcet's disease.

Authors:  Mustafa Nazıroğlu; Mehmet Sahin; Bilal Ciğ; Mehmet Aykur; Ijlal Erturan; Yunus Ugan
Journal:  J Membr Biol       Date:  2014-01-23       Impact factor: 1.843

2.  Colchicine modulates oxidative stress in serum and neutrophil of patients with Behçet disease through regulation of Ca²⁺ release and antioxidant system.

Authors:  Selma Korkmaz; Ijlal Erturan; Mustafa Nazıroğlu; Abdulhadi Cihangir Uğuz; Bilal Ciğ; Ishak Suat Övey
Journal:  J Membr Biol       Date:  2011-11-04       Impact factor: 1.843

3.  Increased oxidative stress in patients with familial Mediterranean fever during attack period.

Authors:  L Ediz; H Ozkol; I Tekeoglu; Y Tuluce; E Gulcu; I Koyuncu
Journal:  Afr Health Sci       Date:  2011-08       Impact factor: 0.927

Review 4.  Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Authors:  Gulen Hatemi; Peter A Merkel; Vedat Hamuryudan; Maarten Boers; Haner Direskeneli; Sibel Z Aydin; Hasan Yazici
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

5.  The association between vitamin D levels and oxidative stress markers in Egyptian Behcet's disease patients.

Authors:  Heba S Omar; Fatma Mohamed Taha; Suzanne Fouad; Fatma A Ibrahim; Aliaa El Gendy; Iman H Bassyouni; Reem El-Shazly
Journal:  Orphanet J Rare Dis       Date:  2022-07-15       Impact factor: 4.303

6.  Noninvasive assessment of impaired endothelial dysfunction in mucocutaneous Behçet's disease.

Authors:  Rifat Eralp Ulusoy; Ozlem Karabudak; Fethi Kilicaslan; Ata Kirilmaz; Melih Hulusi Us; Bekir Sitki Cebeci
Journal:  Rheumatol Int       Date:  2007-12-19       Impact factor: 2.631

7.  Serum prolidase enzyme activity and oxidative status in patients with Behçet's disease.

Authors:  Mehtap Bozkurt; Hatice Yüksel; Serda Em; Pelin Oktayoglu; Mehmet Yildiz; Dicle Akdeniz; Kemal Nas
Journal:  Redox Rep       Date:  2013-11-12       Impact factor: 4.412

8.  A Randomized Double-Masked Phase 2a Trial to Evaluate Activity and Safety of Topical Ocular Reproxalap, a Novel RASP Inhibitor, in Dry Eye Disease.

Authors:  David Clark; John Sheppard; Todd C Brady
Journal:  J Ocul Pharmacol Ther       Date:  2021-01-15       Impact factor: 2.671

9.  Serum Lipid, Lipoprotein and Oxidatively Modified Low Density Lipoprotein Levels in Active or Inactive Patients with Behçet's Disease.

Authors:  Fuat Cimen; Sembol Turken Yildirmak; Andac Ergen; Mustafa Cakmak; Serkan Dogan; Necati Yenice; Funda Sezgin
Journal:  Indian J Dermatol       Date:  2012-03       Impact factor: 1.494

10.  Hyperhomocysteinaemia in Behçet's Disease.

Authors:  Amira Hamzaoui; Olfa Harzallah; Rim Klii; Silvia Mahjoub
Journal:  Biochem Res Int       Date:  2010-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.